全文获取类型
收费全文 | 4979篇 |
免费 | 342篇 |
国内免费 | 16篇 |
专业分类
耳鼻咽喉 | 44篇 |
儿科学 | 99篇 |
妇产科学 | 62篇 |
基础医学 | 757篇 |
口腔科学 | 43篇 |
临床医学 | 493篇 |
内科学 | 1255篇 |
皮肤病学 | 36篇 |
神经病学 | 471篇 |
特种医学 | 274篇 |
外科学 | 835篇 |
综合类 | 11篇 |
一般理论 | 6篇 |
预防医学 | 273篇 |
眼科学 | 38篇 |
药学 | 305篇 |
中国医学 | 2篇 |
肿瘤学 | 333篇 |
出版年
2023年 | 43篇 |
2022年 | 85篇 |
2021年 | 219篇 |
2020年 | 98篇 |
2019年 | 160篇 |
2018年 | 199篇 |
2017年 | 133篇 |
2016年 | 145篇 |
2015年 | 156篇 |
2014年 | 226篇 |
2013年 | 282篇 |
2012年 | 419篇 |
2011年 | 419篇 |
2010年 | 214篇 |
2009年 | 195篇 |
2008年 | 290篇 |
2007年 | 283篇 |
2006年 | 230篇 |
2005年 | 215篇 |
2004年 | 155篇 |
2003年 | 166篇 |
2002年 | 122篇 |
2001年 | 72篇 |
2000年 | 64篇 |
1999年 | 58篇 |
1998年 | 28篇 |
1997年 | 16篇 |
1996年 | 19篇 |
1995年 | 26篇 |
1994年 | 14篇 |
1993年 | 17篇 |
1992年 | 52篇 |
1991年 | 41篇 |
1990年 | 54篇 |
1989年 | 43篇 |
1988年 | 37篇 |
1987年 | 35篇 |
1986年 | 32篇 |
1985年 | 35篇 |
1984年 | 21篇 |
1983年 | 23篇 |
1980年 | 15篇 |
1979年 | 19篇 |
1978年 | 14篇 |
1977年 | 14篇 |
1976年 | 11篇 |
1975年 | 11篇 |
1974年 | 12篇 |
1968年 | 12篇 |
1967年 | 12篇 |
排序方式: 共有5337条查询结果,搜索用时 31 毫秒
51.
M Mathieu 《Annales pharmaceutiques fran?aises》1999,57(5):380-384
Prenatal diagnosis has been introduced in medicine in the seventies with aminocenteses and amniotic cells cultures. It was applied to the diagnosis, during the second trimester of pregnancy for chromosomal abnormalities (mainly Down syndrome in women 38 years of age) and inborn errors of metabolism with very severe handicaps). Since 1970, obstetrical techniques have improved giving access to several fetal biological samples, knowledge in genetics has identified more diseases and biological analyses have become more accurate. During the same time legislation has been instituted: in France the law of 1994 July 29th established rules for prenatal diagnosis. Among theses rules are defined the objective of prenatal diagnosis, the requirement for medical genetic counselling and official authorizations for cytogenetic, infectious diagnosis, biological diagnosis of genetic diseases (biochemical, molecular genetic, hematology, immunology) and maternal plasma markers of chromosomal abnormalities (Down syndrome). Recently (1997 may 28th) have been established "pluridisciplinary prenatal diagnosis centers", including complementary, clinical and biological services to insure the safety of Prenatal Diagnosis. Preimplantation Diagnosis (PID) inherited diseases has become recently possible with the techniques of in vitro fertilization, blastomere biopsy of the early embryo and DNA analysis of the single blastomere. Only a very few centres worldwide offer PID. In France PID is not yet allowed but the National Ethical Committee examined the question and legislation is about to be published. 相似文献
52.
53.
Imbenotte M Azaroual N Mathieu D Cartigny B Vermeersch G Lhermitte M 《Journal of analytical toxicology》1999,23(7):586-590
The application of 1H nuclear magnetic resonance (NMR) spectroscopy to characterize and quantitate paraquat in urine is described. Characterization was performed taking advantage of two NMR spectroscopy parameters: chemical shifts and coupling patterns. Without any pretreatment of the biological samples, herbicide was detected by its aromatic doublets at 8.49 and 9.02 ppm. Quantitation of the xenobiotic was realized by relative integration of the dipyridyl protons to an internal standard. After a validation step using control urine samples, quantitation was performed in urine obtained from two poisoned patients. On admission, mean paraquat concentrations were 985 (patient 1) and 500 (patient 2) micromol/L. Results are compared and found to be in good agreement, using a second-derivative spectroscopy method. 相似文献
54.
55.
Florence Lefranc Tatjana Mijatovic Véronique Mathieu Sandrine Rorive Christine Decaestecker Olivier Debeir Jacques Brotchi Philippe Van Ham Isabelle Salmon Robert Kiss 《Clinical cancer research》2004,10(24):8250-8265
PURPOSE: This study aims to investigate the role of gastrin-17 (G17) on angiogenesis features in gliomas both in vitro and in vivo. EXPERIMENTAL DESIGN: The influences of G17 and G17 receptor antagonists were characterized in vitro in terms of angiogenesis on human umbilical vein endothelial cell (HUVEC) tubulogenesis processes on Matrigel and in vivo with respect to U373 orthotopic glioma xenografts. The influence of phosphatidylinositol 3'-kinase, protein kinase C, and nuclear factor-kappaB inhibitors was characterized in vitro on G17-mediated HUVEC tubulogenesis. G17-mediated release of interleukin (IL)-8 from HUVECs and G17-induced modifications in nuclear factor-kappaB DNA binding activity were characterized by means of specific enzyme-linked immunosorbent assays. The influence of G17 on E- and P-selectin expression was determined by means of computer-assisted microscopy, whereas the influence of E- and P-selectin on HUVEC migration was approached by means of antisense oligonucleotides. The chemotactic influence of G17 and IL-8 on HUVEC migration was characterized by means of computer-assisted videomicroscopy with Dunn chambers. RESULTS: Messenger RNAs for cholecystokinin (CCK)A, CCKB, and CCKC receptors were present in HUVECs and microvessels dissected from a human glioblastoma. Whereas G17 significantly increased the levels of angiogenesis in vivo in the U373 experimental glioma model and in vitro in the HUVECs, the CCKB receptor antagonist L365,260 significantly counteracted the G17-mediated proangiogenic effects. G17 chemoattracted HUVECs, whereas IL-8 failed to do so. IL-8 receptor alpha (CXCR1) and IL-8 receptor beta (CXCR2) mRNAs were not detected in these endothelial cells. Gastrin significantly (but only transiently) decreased the level of expression of E-selectin, but not P-selectin, whereas IL-8 increased the expression of E-selectin. Specific antisense oligonucleotides against E- and P-selectin significantly decreased HUVEC tubulogenesis processes in vitro on Matrigel. CONCLUSIONS: The present study shows that gastrin has marked proangiogenic effects in vivo on experimental gliomas and in vitro on HUVECs. This effect depends in part on the level of E-selectin activation, but not on IL-8 expression/release by HUVECs. 相似文献
56.
Sadeghi H Allard P Shafie K Mathieu PA Sadeghi S Prince F Ramsay J 《Gait & posture》2000,12(3):257-264
Timing in peak gait values shifts slightly between gait trials. When averaged, the standard deviation (S.D.) in gait data may increase due to this inter-trial variability unless normalization is carried out beforehand. The objective of this study was to determine how curve registration, an alignment technique, can reduce inter-subject variability in gait data without perturbing the curve characteristics. Twenty young, healthy men participated in this study each providing a single gait trial. Gait was assessed by means of a four-camera high-speed video system synchronized to a force plate. A rigid body three-segment model was used in an inverse dynamic approach to calculate three-dimensional muscle powers at the hip, knee and ankle. Curve registration was applied to each of the 20 gait trials to align the peak powers. The mean registered peak powers increased by an average of 0.10±0.13 W/kg with the highest increases in the sagittal plane at push-off. After performing curve registration, the RMS values decreased by 13.6% and the greatest reduction occurred at the hip and knee, both in the sagittal plane. No important discontinuities were reported in the first and second derivatives of the unregistered and registered curves. Curve registration did not have much effect on the harmonic content. This would be an appropriate technique for application prior to any statistical analysis using able-bodied gait patterns. 相似文献
57.
Karine Titier Pierre-Olivier Girodet Hélène Verdoux Mathieu Molimard Bernard Bégaud Wilhelm Haverkamp Malcolm Lader Nicholas Moore 《Drug safety》2005,28(1):35-51
Syncope and sudden death are features of schizophrenia that can be attributed to ischaemic heart disease, the use of antipsychotics (because of proarrhythmia or other reasons such as pharyngeal dyskinesia) or the psychiatric disease itself. Cases have been described with most antipsychotics and have led to the withdrawal, temporary suspension from the market or restricted use of antipsychotics, such as sultopride, droperidol, sertindole or thioridazine. Reviewing the available data shows that all antipsychotics tested affect the cardiac potassium channel, with the concentration that produces 50% inhibition (IC50) ranging from 1 nmol/L (haloperidol) to 6 micromol/L (olanzapine). Experimental in vitro or in vivo electrophysiological studies have shown a dose-dependent increase in the duration of the action potential with various degrees of indicators of serious arrhythmogenicity. However, this does not always translate clinically into an increased duration of the QT interval or increased risk of torsade de pointes or sudden death in clinical trials or pharmacoepidemiological studies. In turn, QT prolongation in clinical trials does not always translate to an increased risk of torsade de pointes or sudden death. The reasons for these apparent discrepancies are unclear and could be related to insufficiently powered field studies, low plasma and tissue drug concentrations with reference to in vitro data or drug effects on other receptors or ion channels that have a protective effect. Alternatively, risks that were not apparent from preclinical or clinical data could be related to the use of the drug in high-risk patients, metabolic interactions or other factors that would only be encountered in large postmarketing populations. The assessment of cardiovascular safety, both preclinical and during premarketing clinical trials, needs to be supported by appropriately powered pharmacoepidemiology studies. 相似文献
58.
59.
60.